CAMPBELL NEWMAN ASSET MANAGEMENT INC – Corcept Therapeutics Incorporated Transaction History
CAMPBELL NEWMAN ASSET MANAGEMENT INC portfolio value:
$1.19M
portfolio value
CAMPBELL NEWMAN ASSET MANAGEMENT INC quarter portfolio value change:
+7.82%
quarter
Corcept Therapeutics Incorporated 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +2.45% | 1.11K shares | 113K | $25.64 | 46.65K |
Q2 2022 | share | Increase | +4.53% | 1.97K shares | 102K | $23.78 | 45.54K |
Q1 2022 | share | Increase | +1.98% | 846 shares | 135K | $22.52 | 43.56K |
Q4 2021 | share | Increase | +2.71% | 1.12K shares | 27K | $19.48 | 42.72K |
Q3 2021 | share | Increase | +5.52% | 2.17K shares | -48K | $19.68 | 41.59K |
Q2 2021 | share | Increase | +5.38% | 2.01K shares | -23K | $22 | 39.41K |
Q1 2021 | share | Increase | +4.97% | 1.77K shares | -42K | $23.79 | 37.40K |
Q4 2020 | share | Increase | +8.14% | 2.68K shares | 358K | $26.16 | 35.63K |
Q3 2020 | share | Increase | +1.89% | 611 shares | 30K | $17.41 | 32.95K |
Q2 2020 | share | Increase | +0.95% | 304 shares | 163K | $16.82 | 32.34K |
Q1 2020 | share | Decrease | -4.59% | -1.54K shares | -25K | $11.89 | 32.04K |
Q4 2019 | share | Decrease | -0.16% | -53 shares | -69K | $12.1 | 33.58K |
Q3 2019 | share | Decrease | -0.80% | -271 shares | 97K | $14.14 | 33.63K |
Q2 2019 | share | Increase | +7.17% | 2.26K shares | 7K | $11.15 | 33.90K |
Q1 2019 | share | Increase | +2.64% | 815 shares | -41K | $11.74 | 31.63K |
Q4 2018 | share | Increase | +11.78% | 3.24K shares | 25K | $13.36 | 30.82K |
Q3 2018 | share | Increase | 0.00% | 27.57K shares | 387K | $14.02 | 27.57K |